

Integrating AI with organoids promises faster, more accurate drug development and personalized therapies, potentially reducing reliance on animal testing and improving patient outcomes. As biological computing matures, it could offer energy‑efficient alternatives to traditional silicon chips, making the topic both scientifically groundbreaking and commercially disruptive.
Comments
Want to join the conversation?
Loading comments...